Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive

Data on JCV-DNA in Brazil add to the worldwide assessment of the prevalence of the JCV in MS patients requiring treatment with natalizumab.

Page 1

	Year	Citations
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort A.K. Trampe, Claudia Hemmelmann, Anke Stroet, Neurology	2012	128
JC virus antibody status underestimates infection rates Joseph R. Berger, Sidney A. Houff, Julie A. Gurwell, Annals of Neurology	2013	83
Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy Olivier Outteryck, Jean-Claude Ongagna, Alain Duhamel, Journal of Neurology VaccinationNatalizumab TherapyMs PatientsAutoimmune DiseaseNeurovirology	2012	38
Brain Trauma and Concussion D. Denny‐Brown Archives of Neurology Traumatic Brain InjuryNeuropsychologyNeurological DisorderHead InjuryBrain Lesion	1961	31
Natalizumab adverse events are rare in patients with multiple sclerosis Yára Dadalti Fragoso, Soniza Vieira Alves‐Leon, Walter Oleschko Arruda, Arquivos de Neuro-Psiquiatria	2013	14

Page 1